-
公开(公告)号:US20230220063A1
公开(公告)日:2023-07-13
申请号:US16624130
申请日:2018-06-22
申请人: NOVARTIS AG
发明人: Monica LIGUEROS-SAYLAN , Patrice MATCHABA , Tom THUREN , Paul RIDKER , Peter LIBBY , Penelope OTTEWELL , Yang Yi LAU , Margaret DUGAN
IPC分类号: C07K16/24 , A61K39/00 , A61P35/00 , A61K9/00 , G01N33/574
CPC分类号: C07K16/245 , A61K9/0019 , A61K39/00114 , A61P35/00 , G01N33/57423 , A61K31/282 , A61K2039/54 , A61K2039/82 , A61K2039/86 , A61K2039/505 , A61K2039/545 , A61K2039/828 , A61K2039/836 , A61K2039/868
摘要: Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.